Ipca Labs ties up with biotech firm to develop cancer and autoimmune disease treatments

Ipca Laboratories has signed a global licensing deal with BRL to develop and commercialise biologic therapies for cancer and autoimmune diseases.

Leave a Reply

Your email address will not be published. Required fields are marked *